| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 5.2.1 - Source Exposed (Symptoms, SPT) | 2014 | Spain | IgE | 103 | 15.300 | 20141003, Beitia JM
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2014 | France | IgE | 68 | 36.000 | 20141107, Agabriel C
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2014 | France | IgE | 68 | 50.000 | 20141107, Agabriel C
| | 1.11 - Esophagitis, Diagnosed | 2014 | Spain | IgE | 67 | 3.000 | 20140625, Armentia A
| | 1.1 - Asymptomatic | 2014 | Spain | IgE | 50 | 4.000 | 20140625, Armentia A
| | 1.9 - Pollen Allergy | 2014 | Spain | IgE | 50 | 0.000 | 20140625, Armentia A
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Korea, Republic of | IgE | 25 | 4.000 | 20140821, Choi JS
| | 4.1.1 - Heterologous Source Sensitized (Symptoms) | 2013 | Netherlands | IgE | 81 | 4.880 | 20130415, Masthoff LJ
| | 4.1.1 - Heterologous Source Sensitized (Symptoms) | 2013 | Netherlands | IgE | 79 | 10.130 | 20130415, Masthoff LJ
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 1.300 | 20131020, van Rhijn BD
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 8.570 | 20130605, Simon D
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2013 | Thailand | IgE | 21 | 33.300 | 20131011, Suratannon N
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2013 | Thailand | IgE | 19 | 0.000 | 20131011, Suratannon N
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2012 | South Africa | IgE | 85 | 15.290 | 20120404, Singh T
| | 4.1.6 - Heterologous Source Sensitized (High IgE) | 2012 | France | IgE | 75 | 25.330 | 20120521, Bronnert M
| | 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2012 | Germany | IgE | 47 | 51.060 | 20120206, Blank S
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Denmark | IgE | 30 | 7.000 | 20120410, Ballmer-Weber BK
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Switzerland | IgE | 21 | 10.000 | 20120410, Ballmer-Weber BK
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Denmark | IgE | 20 | 0.000 | 20120410, Ballmer-Weber BK
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Spain | IgE | 20 | 20.000 | 20120410, Ballmer-Weber BK
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Switzerland | IgE | 20 | 15.000 | 20120410, Ballmer-Weber BK
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Spain | IgE | 9 | 11.000 | 20120410, Ballmer-Weber BK
| | 1.10 - Any allergy symptom, Diagnosed | 2011 | Spain | IgE | 1018 | 13.550 | 20111011, Vidal C
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2011 | Sweden | IgE | 74 | 21.620 | 20110701, Moverare R
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Germany | IgE | 65 | 67.690 | 20110401, Mertens M
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2011 | Germany | IgE | 40 | 25.000 | 20110511, Sander I
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Germany | IgE | 22 | 0.000 | 20110401, Mertens M
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2011 | Netherlands | IgE | 20 | 0.000 | 20110304, Vissers YM
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2011 | Germany | IgE | 10 | 60.000 | 20110511, Sander I
| | 6.2 - General Population (Adults) | 2010 | Denmark | IgE | 1197 | 6.430 | 20100401, Linneberg A
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Portugal | IgE | 30 | 6.660 | 20081126, Rodrigus-Alves R
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Switzerland | IgE | 24 | 38.000 | 20091005, Bauermeister K
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Denmark | IgE | 21 | 19.000 | 20090406, Skamstrup Hansen K
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Switzerland | IgE | 21 | 33.000 | 20090406, Skamstrup Hansen K
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Denmark | IgE | 20 | 15.000 | 20090406, Skamstrup Hansen K
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Spain | IgE | 20 | 55.000 | 20090406, Skamstrup Hansen K
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Switzerland | IgE | 20 | 5.000 | 20091005, Bauermeister K
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Switzerland | IgE | 20 | 35.000 | 20090406, Skamstrup Hansen K
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Spain | IgE | 17 | 24.000 | 20090406, Skamstrup Hansen K
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2008 | Switzerland | IgE | 99 | 13.130 | 20081218, Muller UR
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2008 | Switzerland | IgE | 96 | 52.080 | 20081218, Muller UR
|
|
Loading...
Ana c 2.0101 (MUXF3)
